The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
The summit brought together over 150 doctors, researchers, and practitioners worldwide
AI-powered platform uses real-time emotion scanning and personalised interventions to make emotional wellness measurable and actionable
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Extending production capabilities to the Americas helps reduce labor costs and inventory complexity for nutraceuticals and other industries while maintaining superior moisture control
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
The investigational therapy, MDX2003, is designed to go after cancer cells with a multi-pronged immune attack
Three-day programme focuses on advanced socket design, myoelectric technology and clinical skill development
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Subscribe To Our Newsletter & Stay Updated
